Our Services
Medical Information
Helpful Resources
Published on: 9/24/2026
Ringworm on the skin usually clears within 2 to 4 weeks of daily antifungal cream, while scalp, groin, or nail infections often require 4 to 12 weeks or longer of prescription oral antifungals. Itching and redness typically start improving within 3 to 7 days, yet the fungus can survive beneath the surface, so treatment should continue for at least one week after the rash disappears. Several factors change this timeline, including the infection site, your immune health, and whether the rash was misdiagnosed as eczema or psoriasis, so see below to understand more.
If your rash is spreading, not responding after two weeks, or you are unsure it is ringworm at all, a fast self-assessment can help you decide whether a pharmacy cream is enough or a prescription is needed. Take a free, instant, online symptom check to better understand what may be causing your rash and what step to take next.
Last reviewed for medical accuracy: 09/24/2026
Ringworm, medically known as tinea, is a common fungal infection that affects the skin, scalp or nails. Despite its name, it’s not caused by a worm but by microscopic fungi called dermatophytes. Ringworm typically appears as a red, circular rash that can be itchy, scaly or raised. It spreads easily through direct skin contact, shared items (towels, clothing) or contact with infected pets.
With the right treatment and good skin care, most cases of skin-based ringworm clear up in 2–4 weeks. Exact timing depends on:
Here’s a general timeline:
Even when the rash looks gone, continue treatment for the full recommended period. Stopping early can allow the fungus to return.
When choosing an antifungal, consider the affected area, ease of use and whether you need a prescription. Here are top options:
Use these creams, sprays or powders as directed on clean, dry skin. For athlete’s foot, sprays or powders can help keep feet dry.
Your doctor may choose these if OTC products don’t work.
Oral medication is reserved for:
Common oral agents:
Oral drugs require blood tests and monitoring for liver function, especially if you have liver disease or take other medications.
Beyond medication, these steps help speed recovery and prevent reinfection:
Most ringworm clears with proper self-care and OTC treatments. See a doctor if you experience:
You might also consider a free, online symptom check, using the doctor approved Ubie Symptom Checker to help clarify your next steps.
Once you clear ringworm, take steps to avoid getting it again:
Ringworm can be stubborn, but most skin infections respond well to first-line topical antifungals. Nail and scalp cases take longer and require prescription medication. With patience and proper care, you’ll beat it.
Typical timelines:
Always discuss any serious or life-threatening concerns with a healthcare professional. If you have a weakened immune system, widespread infection or signs of systemic illness (fever, fatigue), seek medical advice promptly.
This information is based on guidelines from the Centers for Disease Control and Prevention (CDC), Mayo Clinic and other leading dermatology sources. For personalized advice, speak to your doctor or dermatologist.
Speak to a doctor if you have any serious or persistent symptoms, or if you’re unsure about treatment options.
(References)
* Patel GA, Wiederkehr M, Schwartz RA. Tinea cruris in children. Cutis. 2009 Sep;84(3):133-7. PMID: 19842572.
* Hoffman LK, Raymond I, Kircik L. Treatment of Signs and Symptoms (Pruritus) of Interdigital Tinea Pedis With Econazole Nitrate Foam, 1. J Drugs Dermatol. 2018 Feb 1;17(2):229-232. PMID: 29462232.
* Aleohin N, Bar J, Bar-Ilan E, Samuelov L, Sprecher E, Mashiah J. Laboratory monitoring during antifungal treatment of paediatric tinea capitis. Mycoses. 2021 Feb;64(2):157-161. doi: 10.1111/myc.13197. Epub 2020 Oct 27. PMID: 33064847.
* Inoue T, Watabe D, Tsunemi Y, Amano H. Outcome of fosravuconazole treatment for onychomycosis refractory to topical antifungal agents. J Dermatol. 2023 Aug;50(8):1014-1019. doi: 10.1111/1346-8138.16824. Epub 2023 May 8. PMID: 37157898.
* Du L, Liu L, Zou S, Kou E, Wang B, Zhao H, Dong B, Chen W, Liu L, Wang L, Zhu Y. Interdigital-type antifungal socks for prevention and treatment of tinea pedis. J Infect Public Health. 2024 Jul;17(7):102455. doi: 10.1016/j.jiph.2024.05.043. Epub 2024 May 18. PMID: 38820891.
* Deng R, Chen X, Zheng D, Xiao Y, Dong B, Cao C, Ma L, Tong Z, Zhu M, Liu Z, Lu S, Fu M, Jin Y, Yin B, Li F, Li X, Abliz P, Liu H, Zhang Y, Yu N, Wu W, Xiong X, Zeng J, Huang H, Jiang Y, Chen G, Pan W, Sang H, Wang Y, Guo Y, Shi D, Yang J, Ran Y, Hu J, Yang L, Bai S, Yu J, Wang X, Li R. Epidemiologic features and therapeutic strategies of kerion: A nationwide multicentre study. Mycoses. 2024 Jun;67(6):e13751. doi: 10.1111/myc.13751. PMID: 38825584.
* Khiewplueang K, Leeyaphan C, Bunyaratavej S, Jirawattanadon P, Saengthong-Aram P, Matthapan L, Prasong W, Panyawong C, Plengpanich A. Tinea faciei clinical characteristics, causative agents, treatments and outcomes; a retrospective study in Thailand. Mycoses. 2024 Jun;67(6):e13754. doi: 10.1111/myc.13754. PMID: 38880935.
* Gupta AK, Wang T, Mann A, Polla Ravi S, Talukder M, Lincoln SA, Foreman HC, Kaplan B, Galili E, Piguet V, Shemer A, Bakotic WL. Antifungal resistance in dermatophytes - review of the epidemiology, diagnostic challenges and treatment strategies for managing Trichophyton indotineae infections. Expert Rev Anti Infect Ther. 2024 Sep;22(9):739-751. doi: 10.1080/14787210.2024.2390629. Epub 2024 Aug 18. PMID: 39114868.
* Caplan AS, Gold JAW, Smith DJ, Ely JW. Diagnosis and Management of Tinea Infections. Am Fam Physician. 2025 Oct;112(4):382-392. PMID: 41118183.
* Durdu M, Kandemir H, Karakoyun AS, Lysková P, Kolarczyková D, Bingöl O, Erdem Y, Aktürk-Gözel F, Su-Küçük Ö, Özay M, Yürekli A, Muslu İ, An İ, Özçelik S, Falay-Gür T, Tehçi T, Demirbaş A, Ulutaş-Demirbaş G, Atak T, Taşolar K, Acar-Mantar B, Mülayim MK, Kıran R, Mansur AT, Yanatma İ, Sever S, Yayla-Öztürk Y, Temiz SA, Öztaş-Kara R, Uzun F, Kuşçu F, Erköse-Genç G, Erturan Z, de Hoog S, Hubka V, Ilkit M. Clinical and Mycological Profiles of Chronic and Recalcitrant Dermatophytosis: Türkiye, 2022-2024. Mycopathologia. 2026 Feb 18;191(2):34. doi: 10.1007/s11046-026-01058-5. Epub 2026 Feb 18. PMID: 41706238; PMCID: PMC12916938.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.